Cargando…

Decreased Urine N6-methyladenosine level is closely associated with the presence of diabetic nephropathy in type 2 diabetes mellitus

BACKGROUND: To investigate the dynamic changes of urine N6-methyladenosine (m6A) levels in patients with type 2 diabetes mellitus (T2DM) and diabetic nephropathy (DN) and evaluate the clinical significance. METHODS: First, the levels of urine m6A were examined and compared among 62 patients with T2D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Shu-jun, Hua, Qiang, Xing, Yu-jie, Cheng, Yi, Zhou, Si-min, Sun, Yue, Yao, Xin-ming, Meng, Xiang-jian, Cheng, Jin-han, Wu, Han, Zhai, Qing, Zhang, Yan, Kong, Xiang, Lv, Kun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553099/ https://www.ncbi.nlm.nih.gov/pubmed/36237191 http://dx.doi.org/10.3389/fendo.2022.986419

Ejemplares similares

Anthropometric Measures and Incident Diabetic Nephropathy in Participants With Type 2 Diabetes Mellitus
por: Hukportie, Daniel Nyarko, et al.
Publicado: (2021)

Association Between Globulin and Diabetic Nephropathy in Type2 Diabetes Mellitus Patients: A Cross-Sectional Study
por: Wang, Jian, et al.
Publicado: (2022)

Autophagy and its therapeutic potential in diabetic nephropathy
por: Han, Yu-Peng, et al.
Publicado: (2023)

Association of ANGPTL8 and Resistin With Diabetic Nephropathy in Type 2 Diabetes Mellitus
por: Li, Mengni, et al.
Publicado: (2021)

N6-Methyladenosine-Related Gene Signature Associated With Monocyte Infiltration Is Clinically Significant in Gestational Diabetes Mellitus
por: Du, Runyu, et al.
Publicado: (2022)

New Diagnostic Model for the Differentiation of Diabetic Nephropathy From Non-Diabetic Nephropathy in Chinese Patients
por: Zhang, WeiGuang, et al.
Publicado: (2022)

Decreased IGF-1 level is associated with restrained amino acid metabolism in NSCLC with diabetes mellitus
por: Lv, Hehe, et al.
Publicado: (2022)

Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
por: Dejenie, Tadesse Asmamaw, et al.
Publicado: (2023)

Association of Predicted Lean Body Mass and Fat Mass With Incident Diabetic Nephropathy in Participants With Type 2 Diabetes Mellitus: A Post Hoc Analysis of ACCORD Trial
por: Hukportie, Daniel Nyarko, et al.
Publicado: (2021)

Combining SGLT2 Inhibition With a Thiazolidinedione Additively Attenuate the Very Early Phase of Diabetic Nephropathy Progression in Type 2 Diabetes Mellitus
por: Han, Eugene, et al.
Publicado: (2018)

Association Between Lipoprotein (A) and Diabetic Nephropathy in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis
por: Ren, Xiaoyan, et al.
Publicado: (2021)

Klotho’s impact on diabetic nephropathy and its emerging connection to diabetic retinopathy
por: Tang, Anqi, et al.
Publicado: (2023)

The fragmentomic property of plasma cell-free DNA enables the non-invasive detection of diabetic nephropathy in patients with diabetes mellitus
por: Yu, Chaolun, et al.
Publicado: (2023)

The diagnostic value of lipoprotein-associated phospholipase A2 in early diabetic nephropathy
por: Zhai, Yan, et al.
Publicado: (2023)

N6-methyladenosine RNA modification: an emerging molecule in type 2 diabetes metabolism
por: Zhang, Haocheng, et al.
Publicado: (2023)

Identification and Verification of Diagnostic Biomarkers for Glomerular Injury in Diabetic Nephropathy Based on Machine Learning Algorithms
por: Han, Hongdong, et al.
Publicado: (2022)

A systematic review and meta-analysis of gut microbiota in diabetic kidney disease: Comparisons with diabetes mellitus, non-diabetic kidney disease, and healthy individuals
por: Han, Shisheng, et al.
Publicado: (2022)

Identification of copper-related biomarkers and potential molecule mechanism in diabetic nephropathy
por: Ming, Jie, et al.
Publicado: (2022)

Evidence of Early Diabetic Nephropathy in Pediatric Type 1 Diabetes
por: Mamilly, Leena, et al.
Publicado: (2021)

Is preclinical diabetic retinopathy in diabetic nephropathy individuals more severe?
por: Yao, Hongyan, et al.
Publicado: (2023)

Editorial: Advances in the research of diabetic nephropathy
por: Abu-Farha, Mohamed, et al.
Publicado: (2023)

Role of sex hormones in diabetic nephropathy
por: Liu, Jiahui, et al.
Publicado: (2023)

Endoplasmic reticulum homeostasis: a potential target for diabetic nephropathy
por: Yang, Ming, et al.
Publicado: (2023)

Concurrent Presentation of Diabetic Nephropathy and Type 1 Diabetes Mellitus in a Pediatric Patient
por: Manazir, Sana, et al.
Publicado: (2021)

Dose–response association of Chinese visceral adiposity index with comorbidity of hypertension and diabetes mellitus among elderly people
por: Ren, Yongcheng, et al.
Publicado: (2023)

Reduction in risk of contrast-induced nephropathy in patients with chronic kidney disease and diabetes mellitus by enhanced external counterpulsation
por: Zeng, Chun-Mei, et al.
Publicado: (2022)

A Mendelian randomization study to assess the genetic liability of type 1 diabetes mellitus for IgA nephropathy
por: Deng, Peizhi, et al.
Publicado: (2022)

Genetically Predicted Causality of 28 Gut Microbiome Families and Type 2 Diabetes Mellitus Risk
por: Xiang, Kun, et al.
Publicado: (2022)

Commentary: Is preclinical diabetic retinopathy in diabetic nephropathy individuals more severe?
por: Kameda, Yusuke
Publicado: (2023)

Comparison of characteristics between Chinese diabetes mellitus-induced erectile dysfunction populations and non-diabetes mellitus-induced erectile dysfunction populations: A cross-sectional study
por: Peng, Jingxuan, et al.
Publicado: (2022)

Analysis of urine Raman spectra differences from patients with diabetes mellitus and renal pathologies
por: Kavuru, Varun, et al.
Publicado: (2023)

Establishment and validation of a clinical model for predicting diabetic ketosis in patients with type 2 diabetes mellitus
por: Qi, Mengmeng, et al.
Publicado: (2022)

The Multi-Therapeutic Role of MSCs in Diabetic Nephropathy
por: Wang, Yi, et al.
Publicado: (2021)

Editorial: Diagnosis, prevention and treatment in diabetic nephropathy
por: Rando, Maria Margherita, et al.
Publicado: (2022)

Myokines: Novel therapeutic targets for diabetic nephropathy
por: Yang, Ming, et al.
Publicado: (2022)

The role of cellular crosstalk in the progression of diabetic nephropathy
por: Zhang, Keying, et al.
Publicado: (2023)

Diabetes mellitus with a duration of 26 years combined with IgA nephropathy: A case report and literature review
por: Gou, Yan-Li, et al.
Publicado: (2022)

Causal Association of Type 2 Diabetes Mellitus and Glycemic Traits With Cardiovascular Diseases and Lipid Traits: A Mendelian Randomization Study
por: Huang, Mingkai, et al.
Publicado: (2022)

A systematic review and Meta-analysis of urinary extracellular vesicles proteome in diabetic nephropathy
por: Ding, Xiaonan, et al.
Publicado: (2022)

Association of intercellular adhesion molecule 1 (ICAM1) with diabetes and diabetic nephropathy
por: Gu, Harvest F., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hiql89bekl7cevmggar3akhqqp